AFFINITY: Assessment of fluoxetine in stroke recovery trial


Lead PI:  Dr Graeme J Hankey and Associate Professor Maree L. Hackett

Status: Recruiting

No. of Patients Currently Recruited: 246                                No. of Patients Required:  1600

An Australian-lead investigator initiated, multi-centre, prospective, randomized, parallel group, double blind placebo-controlled trial to establish the effect(s) of routine administration of fluoxetine (20mg once daily) for 6 months in patients with recent stroke on functional outcome at 6 months and one year.

Trial URL:

ANZCTR No: ACTRN12611000774921


Last Updated ( Wednesday, 06 July 2016 15:11 )